The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure

Ji, PJ; Zhang, ZY; Yan, Q; Cao, HL; Zhao, YJ; Yang, B; Li, J

Li, J (通讯作者),Shan Xi Med Univ, Hosp 2, Dept Endocrinol & Metab, 56 Xin Jian Rd, Taiyuan, Shan Xi, Peoples R China.

ESC HEART FAILURE, 2023; 10 (2): 1314

Abstract

AimsNo studies have comprehensively compared the efficacy of sodium-glucose cotransporter-2 (SGLT2) inhibitors, renin-angiotensin system (RAS) inhibit......

Full Text Link